![]() |
市場調查報告書
商品編碼
1479979
分子診斷的全球市場,到2029年的預測Global Molecular Diagnostics Market, Forecast to 2029 |
分子診斷激發成長機會並推動創新的個人化醫療
由於多種因素,包括 COVID-19 大流行導致的需求增加、癌症病例數量增加以及技術力的快速發展,全球分子診斷市場預計將顯著成長。
聚合酵素鏈鎖反應(PCR)、數位 PCR 和次世代定序(NGS)等技術的進步提高了分子檢測的準確性和生產力,並實現了個人化治療。
預測分析按區域和應用程式進行細分。後者包括傳染病檢查、腫瘤學檢測、基因檢測和其他分子診斷。由於方法上的限制,Frost & Sullivan對該行業的預測採用定性方法進行成長機會分析。
癌症發生率的增加加速了對先進分子診斷工具的需求,而慢性病的增加、政府醫療保健的現代化以及對個人化醫療的需求不斷增加將推動分子診斷行業的顯著成長。集中的醫療監管和強大的研發投資將促進這一擴張。
Molecular Diagnostics Unleash Growth Opportunities, Steering Innovation Personalized Medicine
The global molecular diagnostic market will experience significant growth due to a broad range of factors, such as increased demand from the COVID-19 pandemic, an increasing number of cancer cases, and the swift evolution of technological capabilities.
Technological advancements, such as polymerase chain reaction (PCR), digital PCR, and next-generation sequencing (NGS), have improved molecular testing accuracy and productivity, enabling personalized treatment.
The forecast analysis is segmented by region and by application. The latter includes infectious disease testing, oncology testing, genetic testing, and other molecular diagnostics. Frost & Sullivan's forecasts for this industry use a qualitative approach for the growth opportunity analyses due to methodological constraints.
The growing prevalence of cancer has accelerated the need for advanced molecular diagnostic tools, while the rise in chronic diseases, the modernization of government healthcare, and the growing demand for personalized medicine will contribute to the significant growth anticipated in the molecular diagnostics industry. Focused healthcare regulations and substantial R&D investments facilitate this expansion.